Montmorency tart cherry supplementation does not impact sleep, body composition, cellular health, or blood pressure in healthy adults.

Background: Sleep disturbances are linked with cardiovascular and metabolic disease as well as poor body composition. Aim: To investigate the use of tart cherry supplements, which are high in antioxidants and may contain melatonin, on parameters of health such as sleep, body composition, cellular health, and blood pressure (BP). Methods: Forty-four participants had completed sleep record data and were included in this analysis. Participants consumed either two 240 ml bottles per day of Montmorency tart cherry (MTC) juice or placebo or two capsules per day of powdered MTC or placebo for 30 days. Participants tracked their sleep daily via questionnaire and completed body composition and BP assessments at baseline, 14 days, and 30 days after supplementation. Results: There were no significant differences in sleep time or quality between groups, though both increased over 30 days. The capsule groups had significantly lower body mass (BM) 14 days versus baseline for placebo group (p = 0.01, mean difference: 0.70 kg) and at 30 days versus 14 days in MTC group (p = 0.02, mean difference: 0.75 kg). No other differences in body composition or cellular health were found. BP was unaffected by MTC supplementation over 30 days. Despite the potential benefits of antioxidants and melatonin, we did not find improvements in sleep time or quality, cellular health or BP in participants consuming MTC for 30 days, though BM decreased in capsule groups. Conclusion: These results conflict with previous data on MTC and sleep and BP, therefore further investigation is warranted.